Table 4 Association between circulating miR-1290 expression and clinicopathologic characteristics in 50 gastric cancer patients.

Age (year)

63.74±1.62

65.58±1.78

60.18±3.19

0.115

Sex

0.616

 Male

26

18

8

 Female

24

15

9

BMI (kg/m²)

22.33 (20.50-25.11)

22.27 (20.38-25.06)

22.48 (20.49-25.50)

0.690

Smoke

0.334

 Yes

13

10

3

 No

37

23

14

Alcohol

0.520

 Yes

12

7

5

 No

38

26

12

Hypertension

0.031*

 Yes

12

11

1

 No

38

22

16

Diabetes

0.134

 Yes

4

4

0

 No

46

29

17

Tumor size (cm)

4.00 (1.93-5.50)

4.50 (2.00-5.45)

4.00 (0.70-7.00)

0.498

Lymphatic invasion

0.261

 Positive

29

21

8

 Negative

21

12

9

Venous invasion

0.370

 Positive

25

18

7

 Negative

25

15

10

Distant metastasis

0.613

 Positive

14

10

4

 Negative

36

23

13

Differentiation

0.526

 Well

9

5

4

 Moderate

12

7

5

 Poor

29

21

8

TNM stage (AJCC)

0.754

 I and II

28

19

9

 III and IV

22

14

8

CRP (mg/l)

0.218

 < 10

47

32

15

 ≥ 10

3

1

2

CEA (ng/ml)

0.235

 < 5

43

27

16

 ≥ 5

7

6

1

CA199 (U/ml)

0.410

 < 37

41

26

15

 ≥ 37

9

7

2

CA125 (U/ml)

0.963

 < 35

41

27

14

 ≥ 35

9

6

3

CA242 (U/ml)

0.692

 < 20

46

30

16

 ≥ 20

4

3

1

CA211 (ng/ml)

0.486

 < 5

45

29

16

 ≥ 5

5

4

1